The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical experience with ferric carboxymaltose as treatment of cancer-associated anemia.
T. Steinmetz
Consultant or Advisory Role - Vifor Pharma
B. Tschechne
Consultant or Advisory Role - Vifor Pharma
G. Virgin
Employment or Leadership Position - Vifor Pharma
M. Felder
Employment or Leadership Position - Vifor Pharma
J. Wamhoff
No relevant relationships to disclose
H. Tesch
Consultant or Advisory Role - Vifor Pharma
R. Rohrberg
Consultant or Advisory Role - Vifor Pharma
N. Marschner
Consultant or Advisory Role - Vifor Pharma
Research Funding - Vifor Pharma